Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCRζ/CD3 induction of interleukin-2

Immunity

Volumn 6, Issue 2, 1997, Pages 155-164

  Raab, Monika ^c   Da Silva, Antonio J ^a   Findell, Paul R ^b   Rudd, Christopher E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; INTERLEUKIN 2; PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNOBLOTTING; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; T LYMPHOCYTE;

EID: 0030906543     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80422-7     Document Type: Article

References (46)

1. Brown, M., and Faulkner, P. (1977). A plaque assay for nuclear polyhedrosis viruses using a solid overlay. J. Gen. Virol. 36, 361-364.
2. Bubeck Wardenburg, J., Chong, F., Jackman, J.M., Flotow, H., Wilkinson, S.E., Williams, D.H., Johnson, R., Kong, G., Chan, A.C., and Findell, P.R. (1996). Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T cell receptor function. J. Biol. Chem. 271, 19641-19644.
3. fyn. Proc. Natl. Acad. Sci. USA 89, 9311-9315.
4. Bustelo, X., and Barbacid, M. (1992). Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells. Science 256, 1196-1199.
5. Bustelo, X.R., Suen, K.L., Leftheris, K., Meyers, C.A., and Barbacid, M. (1994). Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor. Oncogene 9, 2405-2413.
6. Chan, A.C., Dalton, M., Johnson, R., Kong, G.H., Wang, T., Thoma, R., and Kurosaki, T. (1995). Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 14, 2499-2508.
7. fyn(T). J. Exp. Med. 178, 2107-2113.
8. da Silva, A.J., Rosenfield, J.M., Mueller, I., Bouton, A., Hirai, H., and Rudd, C.E. (1997). Biochemical analysis of p120/p130: a protein-tyrosine kinase substrate restricted to T and myeloid cells. J. Immunol. 158, 2007-2016.
9. Donovan, J.A., Wange, R.L., Langdon, W.Y., and Samelson, L.E. (1994). The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat cells activated via the T cell antigen receptor. J. Biol. Chem. 269, 22921-22924.
10. Fantl, W.J., Escobeddo, J.A., Martin, G.A., Turck, M., Del Rosario, F., McCormick, F., and Williams, L.T. (1992). Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 69, 413-423.
11. Fischer, K.-D., Zmuldzinas, A., Gardner, S., Barbacid, M., Berstein, A., and Guidos, C. (1995). Defective T-cell receptor signaling and positive selection of vav-deficient CD4+CD8+ thymocytes. Nature 374, 474-477.
12. Gillis, S., Frem, M.M., Ou, W., and Smith, K.A. (1978). T cell growth factor: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027-2032.
13. Gouy, H., Debre, P., and Bismuth, G. (1995). The proto-oncogene Vav product is constitutively tyrosine-phosphorylated in normal human immature T cells. J. Immunol. 25, 3030-3034.
14. Gulbins, E., Coggeshall, K.M., Baier, G., Katzav, S., Burn, P., and Altman, A. (1993). Tyrosine kinase-stimulated guanine nucleotide exchange activity of vav in T cell activation. Science 260, 822-825.
15. Iwashima, M., Irving, B.A., van Oers, N.S.C., Chan, A.C., and Weiss, A. (1994). Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263, 1136-1139.
16. Jackman, J.K., Motto, D.G., Sun, Q., Tanemoto, M., Turck, C.W., Peltz, G.A., Koretzky, G.A., and Findell, P.R. (1995). Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270, 7029-7032.
17. Katzav, S., Martin-Zanca, D., and Barbacid, M. (1989). Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8, 2283-2290.
18. Katzav, S., Sutherland, M., Packham, G., Yi, T., and Weiss, A. (1994). The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-vav. J. Biol. Chem. 269, 32579-32585.
19. Khosravi-Far, R., Chrzanowska-Wodnicka, M., Soski, P.A., Eva, A., Burridge, K., and Der, C.J. (1994). Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol. Cell. Biol. 14, 6848-6857.
20. Koch, C.A., Anderson, D., and Moran, M.F. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-674.
21. Margolis, B., Hu, P., Katzav, S., Oliver, J.M., Ullrich, A., Weiss, A., and Schlessinger, J. (1992). Tyrosine phosphorylation of vav: a proto-oncogene combining SH2 and SH3 domains with motifs found in transcriptional factors. Nature 356, 71-74.
22. McKenney, D.W., Onodera, H., Gorman, L., Minura, T., and Rothstein, D.M. (1995). Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J. Biol. Chem. 270, 24949-24954.
23. Motto, D.G., Ross, E.E., Wu, J., Hendricks-Taylor, L.R., and Koretzky, G.A. (1996). Implication of the GRB-2 associated phosphoprotein SLP-76 in TCP-mediated IL-2 production. J. Exp. Med. 183, 1937-1943.
24. Mustelin, T. (1994). T cell antigen receptor signaling: three families of tyrosine kinases and a phosphatase. Immunity 1, 351-356.
25. Onodera, H., Motto, D.G., Koretzky, G.A., and Rothstein, D.M. (1996). Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein tyrosine phosphatase. J. Biol. Chem. 271, 22225-22230.
26. Pluskey, S., Wandless, T.J., Walsh, C.T., and Shoelson, S.E. (1995). Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J. Biol. Chem. 270, 2897-2900.
27. Prasad, K.V.S., Yun-Cai, C., Raab, M., Duckworth, B., Cantley, L., Shoelson, S.E., and Rudd, C.E. (1994). T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc. Natl. Acad. Sci. USA 91, 2834-2838.
28. Raab, M., and Rudd, C.E. (1996). Hematopoietic cell phosphatase (HCP) regulates p56lck phosphorylation and ZAP-70 binding to the T cell receptor ζ chain. Biochem. Biophys. Res. Commun. 222, 50-57.
29. Raab, M., Yamamoto, M., and Rudd, C.E. (1994). The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck. Mol. Cell. Biol. 14, 2862-2870.
30. fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl. Acad. Sci. USA 92, 8891-8895.
31. Ravichandran, K.S., Lee, K.K., Wade, J., Pawson, T., and Bowtell, D. (1993). Interaction of Shc with the ζ chain of the T cell receptor upon T cell activation. Science 262, 902-904.
32. Reedquist, K.A., Fukazawa, T., Panchamoorthy, G., Langdon, W.Y., Shoelson, S.E., Druker, B.J., and Band, H. (1996). Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J. Biol. Chem. 277, 8435-8442.
33. Roussel, R.R., Brodeur, S.R., Shalloway, D., and Laudano, A.P. (1991). Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src. Proc. Natl. Acad. Sci. USA 88, 10696-10700.
34. Rudd, C.E., Janssen, O., Cai, Y.C., da Silva, A.J., Raab, M., and Prasad, K.V.S. (1994). Two step TcRζ/CD3-CD4 and CD28 signalling in T-cells. Immunol. Today 15, 225-234.
35. Samelson, L.E., and Klausner, R.D. (1992). Tyrosine kinases and tyrosine-based activation motifs. J. Biol. Chem. 267, 24913-24916.
36. Tarakhovsky, A., Turner, M., Schaal, S., Joseph Mee, P., Duddy, L.P., Rajewsky, K., and Tybulewicz, V.L.J. (1995). Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 374, 467-470.
37. Wange, R.L., and Samelson, L.E. (1996). Complex complexes: signaling at the TCR. Immunity 5, 197-205.
38. Wange, R.L., Malek, S.N., Desiderio, S., and Samelson, L.E. (1993). Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor ζ and CD3ε from activated Jurkat Tcells. J. Biol. Chem. 268, 19797-19801.
39. Wange, R.L., Guitian, R., Isakov, N., Watts, J.D., Aebersold, R., and Samelson, L.E. (1995). Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 270, 18730-18733.
40. Weiss, A., and Littman, D.R. (1994). Signal transduction of lymphocyte antigen receptors. Cell 76, 263-274.
41. Weiss, A., Koretzky, G., Schatzman, R.C., and Kadlecek, T. (1991). Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-γl. Proc. Natl. Acad. Sci. USA 88, 5484-5488.
42. Wu, J., Motto, D.G., Koretzky, G.A., and Weiss, A. (1996). Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4, 593-602.
43. Ye, Z.S., and Baltimore, D. (1994). Binding of Vav to Grb2 through dimerization of Src homology 3 domains. Proc. Natl. Acad. Sci. USA 91, 12629-12633.
44. Yun-Cai, C., Cefai, D., Schneider, H., Raab, M., Nabavi, N., and Rudd, C.E. (1995). Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 3, 417-426.
45. lck correlates with impaired function in vitro and lack of expression in vivo. Nature 342, 278-281.
46. Zhang, R., Alt, F.W., Davidson, L., Orkin, S.H., and Swat, W. (1995). Defective signaling through the T and B cell antigen receptors in lymphoid cells lacking the vav proto-oncogne. Nature 374, 470-473.